Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59551 - 59575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	TTK	7272	downregulated	Piroxicam results in decreased expression of TTK mRNA	6q14.1	A23661
Piroxicam	Approved Investigational	TUBA1A	7846	downregulated	Piroxicam results in decreased expression of TUBA1A mRNA	12q13.12	A23661
Piroxicam	Approved Investigational	TXNDC9	10190	downregulated	Piroxicam results in decreased expression of TXNDC9 mRNA	2q11.2	A23661
Piroxicam	Approved Investigational	TXNIP	10628	downregulated	Piroxicam results in decreased expression of TXNIP mRNA	1q21.1	A23661
Piroxicam	Approved Investigational	TXNIP	10628	upregulated	Piroxicam results in increased expression of TXNIP mRNA	1q21.1	A21015
Piroxicam	Approved Investigational	UBE2A	7319	downregulated	Piroxicam results in decreased expression of UBE2A mRNA	Xq24	A23661
Piroxicam	Approved Investigational	UBE2B	7320	downregulated	Piroxicam results in decreased expression of UBE2B mRNA	5q31.1	A23661
Piroxicam	Approved Investigational	UBE2L3	7332	upregulated	Piroxicam results in increased expression of UBE2L3 mRNA	22q11.21	A23661
Piroxicam	Approved Investigational	UBE2N	7334	downregulated	Piroxicam results in decreased expression of UBE2N mRNA	12q22	A23661
Piroxicam	Approved Investigational	UBR7	55148	downregulated	Piroxicam results in decreased expression of UBR7 mRNA	14q32.12	A23661
Piroxicam	Approved Investigational	UCHL5	51377	downregulated	Piroxicam results in decreased expression of UCHL5 mRNA	1q31.2	A23661
Piroxicam	Approved Investigational	UNG	7374	downregulated	Piroxicam results in decreased expression of UNG mRNA	12q24.11	A23661
Piroxicam	Approved Investigational	USP1	7398	downregulated	Piroxicam results in decreased expression of USP1 mRNA	1p31.3	A23661
Piroxicam	Approved Investigational	USP16	10600	upregulated	Piroxicam results in increased expression of USP16 mRNA	21q21	A23661
Piroxicam	Approved Investigational	USP46	64854	downregulated	Piroxicam results in decreased expression of USP46 mRNA	4q12	A23661
Piroxicam	Approved Investigational	UTP11	51118	downregulated	Piroxicam results in decreased expression of UTP11 mRNA	1p34.3	A23661
Piroxicam	Approved Investigational	VCP	7415	downregulated	Piroxicam results in decreased expression of VCP mRNA	9p13.3	A23661
Piroxicam	Approved Investigational	VDAC3	7419	downregulated	Piroxicam results in decreased expression of VDAC3 mRNA	8p11.21	A23661
Piroxicam	Approved Investigational	VEGFA	7422	downregulated	Piroxicam results in decreased expression of VEGFA mRNA	6p21.1	A23661
Piroxicam	Approved Investigational	VPS28	51160	downregulated	Piroxicam results in decreased expression of VPS28 mRNA	8q24.3	A23661
Piroxicam	Approved Investigational	VRK1	7443	downregulated	Piroxicam results in decreased expression of VRK1 mRNA	14q32.2	A23661
Piroxicam	Approved Investigational	VRK2	7444	downregulated	Piroxicam results in decreased expression of VRK2 mRNA	2p16.1	A23661
Piroxicam	Approved Investigational	WARS	7453	downregulated	Piroxicam results in decreased expression of WARS mRNA	14q32.2	A23661
Piroxicam	Approved Investigational	WISP2	8839	upregulated	Piroxicam results in increased expression of WISP2 mRNA	20q13.12	A21015
Piroxicam	Approved Investigational	XPC	7508	downregulated	Piroxicam results in decreased expression of XPC mRNA	3p25.1	A23661

Displaying entries 59551 - 59575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability